Brind.

Citibank upgraded its price target while Deutsche Bank maintained a negative rating for AstraZeneca.

1 report, 1 independent Updated Jul 28
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Citibank upgraded its price target while Deutsche Bank maintained a negative rating for AstraZeneca.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

  • AstraZeneca

    company in Osaka, Japan

    Nothing else this week.

  • Citibank

    American multinational bank

    Nothing else this week.

  • Deutsche Bank

    German global banking and financial services company

    Nothing else this week.

Related events

Coverage

Newest first; wire copies grouped